RFK Jr. and Peptides: Regulatory Scrutiny Intensifies
The intersection of politics and peptide therapy has once again captured headlines, as recent reporting from STAT News highlights increased scrutiny on both Chinese clinical trial sites and Robert F. Kennedy Jr.’s involvement with peptide-related matters. For followers of Tony Huge and the broader biohacking community, these developments signal potential regulatory shifts that could impact […]
Selank: The Russian Anxiolytic Peptide — My 8-Week Protocol and Bloodwork
Selank is the Russian anti-anxiety peptide that kills stress without sedating you. My intranasal protocol, dosing, stacking, and 8 weeks of HRV and GAD-7 data.
RFK Jr. Pushes for Easier Peptide Access as FDA Resists
The ongoing debate between regulatory accessibility and pharmaceutical oversight has reached a critical juncture as Robert F. Kennedy Jr. advocates for easier access to therapeutic peptides, a position that places him at odds with FDA scientists. This development, reported by NBC News, has significant implications for the bodybuilding, biohacking, and longevity optimization communities—areas where Tony […]
The Smart Way to Regulate the Peptide Boom: Industry Analysis
The peptide industry is experiencing unprecedented growth, and with expansion comes scrutiny. A recent STAT News article titled “The smart way to regulate the peptide boom” has sparked conversations across the biohacking and bodybuilding communities about the future of peptide access and regulation. For those following Tony Huge’s work in performance enhancement and longevity optimization, […]
HIMS Peptides Campaign Emerges as FDA Meeting Looms
The telehealth and wellness sector is experiencing turbulence as HIMS & HERS Health, Inc. faces its worst trading week in two months while simultaneously pivoting toward an aggressive peptides marketing campaign. This strategic move comes as the company prepares for a potentially industry-defining FDA meeting that could reshape the landscape of peptide accessibility—a development that […]
FDA Panel Reviews Seven Peptides: What It Means for Users
The peptide community is watching closely as an fda advisory panel prepares to review seven specific peptides this week, a regulatory development that could have significant implications for bodybuilders, biohackers, and longevity enthusiasts who have incorporated these compounds into their protocols. According to NBC News, this fda advisory panel meeting represents a critical moment in […]
Top 3 Peptides: Repair, Skin & Weight Loss Explained
The peptide revolution continues to gain momentum as more athletes, biohackers, and health optimization enthusiasts discover the powerful benefits these amino acid chains offer. Recent coverage from The Killeen Daily Herald highlighting the top three peptides for repair, skin health, and weight loss in Australia reflects a growing global interest in these compounds—a topic that […]
BPC-157 and TB-500 Safety: ConsumerLab Analysis
The peptide community received significant attention this week as ConsumerLab.com, a leading independent testing organization, published an analysis examining the safety and effectiveness of popular peptides BPC-157 and TB-500. For followers of Tony Huge and the broader biohacking community, this development represents an important moment in the ongoing conversation about peptide research and application in […]
TRT at 35+: What Tony Huge Learned From a Decade of Bloodwork
I’ve been optimizing my testosterone for over a decade. I’ve run it every way it can be run — low dose TRT, higher therapeutic doses, cycles, blasts, cruises, and periods completely on my own natural production. I’ve had bloodwork done more times than most people have had checkups. And I’ve watched hundreds of men go […]
FDA Backs TRT Label Expansion for Low Libido in Men
In a significant regulatory shift that could reshape testosterone replacement therapy (TRT) access for millions of men, the Food and Drug Administration has signaled support for expanding TRT product labels to include low libido as a treatable indication. This development, reported by Renal and Urology News, represents a potential paradigm shift in how the medical […]